Evidence map›Paper›PMID 35745846›Full record

ArticlePharmaceutics2022

PLGA Carriers for Controlled Release of Levofloxacin in Anti-Tuberculosis Therapy.

Evgeny N Antonov, Sofya N Andreevskaya, Irina V Bocharova, Sergei E Bogorodsky, Larisa I Krotova, Elena E Larionova, Alexandra O Mariyanats, Gennady V Mishakov, Tatiana G Smirnova, Larisa N Chernousova and 1 more

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Evgeny N AntonovInstitute of Photon Technologies, Federal Scientific Research Centre "Crystallography and Photonics" of Russian Academy of Sciences, 108840 Moscow, Russia.ORCID 0000-0001-9086-1741
Sofya N AndreevskayaCentral Tuberculosis Research Institute, 107564 Moscow, Russia.
Irina V BocharovaCentral Tuberculosis Research Institute, 107564 Moscow, Russia.
Sergei E BogorodskyInstitute of Photon Technologies, Federal Scientific Research Centre "Crystallography and Photonics" of Russian Academy of Sciences, 108840 Moscow, Russia.
Larisa I KrotovaInstitute of Photon Technologies, Federal Scientific Research Centre "Crystallography and Photonics" of Russian Academy of Sciences, 108840 Moscow, Russia.ORCID 0000-0001-7752-2921
Elena E LarionovaCentral Tuberculosis Research Institute, 107564 Moscow, Russia.
Alexandra O MariyanatsInstitute of Photon Technologies, Federal Scientific Research Centre "Crystallography and Photonics" of Russian Academy of Sciences, 108840 Moscow, Russia.ORCID 0000-0002-2743-0858
Gennady V MishakovInstitute of Photon Technologies, Federal Scientific Research Centre "Crystallography and Photonics" of Russian Academy of Sciences, 108840 Moscow, Russia.
Tatiana G SmirnovaCentral Tuberculosis Research Institute, 107564 Moscow, Russia.
Larisa N ChernousovaCentral Tuberculosis Research Institute, 107564 Moscow, Russia.
Vladimir K PopovInstitute of Photon Technologies, Federal Scientific Research Centre "Crystallography and Photonics" of Russian Academy of Sciences, 108840 Moscow, Russia.
Russian Academy of Sciences · RUCentral Scientific Research Institute of Tuberculosis Russian Academy of Medical Sciences · RU

Funding

Russian Foundation for Basic Research 18-29-06062 mk
6 · The paper itself

Abstract

Levofloxacin (LFX) is a highly effective anti-tuberculosis drug with a pronounced bactericidal activity against

Indexed as

anti-tuberculosis drugslevofloxacinPLGA microparticles and scaffoldssupercritical fluid technologiessustained release formulations

Identifiers

PMID35745846
PMCPMC9227258
OpenAlexW4283017572

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.